Johnson & Johnson one-shot vaccine has been approved by the US FDA
The Johnson & Johnson one-shot vaccine has been approved by the US FDA this weekend which now makes it the third approved vaccine for the US, risk-on news for the open this week when vaccinations will begin.
And for the first time since early November, fewer than 50,000 patients are hospitalized with Covid-19. Also, there's been a decrease in new cases and deaths since the abysmal January surge.
Market implications
A lifeline will have been thrown to Us equities on the developments, albeit much of which is already priced in as the markets presume the best.
The week ahead will also be focussed on progress in the relief package and US economic data, including Nonfar, Payrolls.
Reprinted from FXStreet，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.